Sensex gains by more than 200 points; IRCTC jumps by nearly 4 per cent; Trent slumps by more than 4 per cent
Sensex gains by more than 200 points; IRCTC jumps by nearly 4 per cent; Trent slumps by more than 4 per cent

Sensex gains by more than 200 points; IRCTC jumps by nearly 4 per cent; Trent slumps by more than 4 per cent

Geyatee Deshpande Article rating: 5.0

The Sensex closed today at 38407.01 by gaining 224.93 points or by 0.59 per cent whereas the Nifty registered 52.35 points or 0.46 per cent to settle at 11322.50. The metal, banking stock and pharma stock did well in today’s buying session.

Op-ed: Sabse Pehle Life Insurance Campaign
Op-ed: Sabse Pehle Life Insurance Campaign

Op-ed: Sabse Pehle Life Insurance Campaign

Henil Shah Article rating: 3.1

Like AMFI did campaigning for mutual funds, now even Life Insurance Council has come up with such a campaign for life insurance.

IndiGo to raise up to Rs 4,000 crore via QIP; stock recovers from March low
IndiGo to raise up to Rs 4,000 crore via QIP; stock recovers from March low

IndiGo to raise up to Rs 4,000 crore via QIP; stock recovers from March low

Geyatee Deshpande Article rating: 4.8

InterGlobe Aviation, which runs one of India’s most popular airlines IndiGo, announced that the company’s board of directors has approved fundraising of up to Rs 4,000 crore through the issuance of equity shares by way of a qualified institutional placement (QIP).

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 4.7

The market opened in green on August 11, 2020, overall volumes in futures & options currently stand at 1,48,78,121 crore contracts with a turnover of Rs. 10,49,122.07 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 4.5

The market opened in green on August 11, 2020, overall volumes in futures & options currently stand at 1,48,78,121 crore contracts with a turnover of Rs. 10,49,122.07 crore.

Dr Reddy's Laboratories launch generic version of Ciprodex
Dr Reddy's Laboratories launch generic version of Ciprodex

Dr Reddy's Laboratories launch generic version of Ciprodex

Amir Shaikh Article rating: 4.5

Dr Reddy's Laboratories informed the bourses that along with its US subsidiary, it has launched Ciprofloxacin 0.3 per cent and Dexamethasone 0.1 per cent Otic Suspension, USP, a therapeutic equivalent generic version of Ciprodex

Gufic Lifesciences signs pact with Hetero Labs for Remdesivir lyophilised powder
Gufic Lifesciences signs pact with Hetero Labs for Remdesivir lyophilised powder

Gufic Lifesciences signs pact with Hetero Labs for Remdesivir lyophilised powder

Apurva Joshi Article rating: 3.4

Gufic Lifesciences Private Limited (GLPL) has entered into a loan license agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder for injection (100 mg/vial) on loan license basis to Hetero for its sale in various countries, including India.

RSS
First21602161216221632165216721682169Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR